Home › Funds › Andera Partners › KMTS

Andera Partners position in KMTS

KESTRA MEDICAL TECHNOLOGIES · Health Care

Andera Partners reported holding 2,728,679 shares of KMTS (KESTRA MEDICAL TECHNOLOGIES) in its Q3 2026 13F filing — a position valued at US$77.2M, representing 43.94% of its reported portfolio and ranking #1 among its reported holdings. Andera Partners has disclosed KMTS holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)2.73M sh
Reported value held$77.19M
Portfolio Weight43.94%
First reportedQ4 2025
Last changeHold
Updated2026-10-17

Last updated: 2026-10-17 · Source: SEC EDGAR Form 13F-HR

How Andera Partners's KMTS position evolved

Andera Partners first disclosed a stake in KMTS in Q4 2025 at 2,540,106 shares (US$67.4M). The position peaked in Q3 2026 at 2,728,679 shares, worth US$77.2M. Across 4 filings, Andera Partners increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 2,728,679 shares valued at US$77.2M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 2.54M $67.36M New
Q1 2026 2.70M $53.72M Add
Q2 2026 2.73M $69.42M Add
Q3 2026 2.73M $77.19M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KMTS and 13F data

KMTS (KESTRA MEDICAL TECHNOLOGIES) is a Health Care company. 70 other funds we track also report a position in KMTS — the largest reported positions include BAIN CAPITAL INVESTORS LLC (US$640.4M), Yu Fan (US$58.1M), Omega Fund Management, LLC (US$26.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KMTS

All KMTS fund holders →

FAQ

How long has Andera Partners held KMTS?

Andera Partners has disclosed KMTS holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Andera Partners's current position in KMTS?

As of Q3 2026, Andera Partners holds 2.73M shares of KMTS (KESTRA MEDICAL TECHNOLOGIES), valued at $77.19M, representing 43.94% of its reported portfolio and ranking #1.

Has Andera Partners been buying or selling KMTS?

In the latest 13F filing (Q3 2026), Andera Partners held unchanged its position in KMTS. The position peaked in Q3 2026 at 2.73M shares.

Which other funds hold KMTS?

Other major institutional holders of KMTS include BAIN CAPITAL INVESTORS LLC, Yu Fan, Omega Fund Management, LLC, among 70 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.